sensitive skin
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ?18-65 years old females those who have extremely dry skin and pruritus, or previous experience barrier damage, eczema or atopic dermatitis ?Those who have a VAS score between 2.5 cm and 7.4 cm after using the wash-out product for 7 days. ?Those who have a redness score of 1 or more and less than 3 in visual assessment by dermatologist. ?Those who fully understand the objective and contents of the study and voluntarily decide to participate. ?Those who understand the possible adverse reactions and sign the informed consent form. ?Those who do not have acute or chronic diseases including skin diseases which can affect the study (severe infections or eczematous skin diseases including atopic dermatitis). ?Those who are available for observations throughout the entire study. ?Those who are able to visit the laboratory according to set schedules and follow the study instructions.
Exclusion criteria
Exclusion criteria: ?Those who have experienced allergic reactions to cosmetics or have sensitive and hyper-sensitive skin. ?Those who are pregnant, breast feeding or planning pregnancy. ?Those who have prominent nutrition disorder. ?Those who are drug addict or alcoholic. ?Those who have moles, acne, tattoo, scars, red spots, telangiectasis, burns, etc. in the test site. ?Those who have participated in the same clinical evaluation within 6 months. ?Those who have been using steroid or retinoid for treatment of skin disease more than 1 month or are taking medicines which can affect the skin (e.g.,anti-histamines, immunosuppressants). ?Those who have used cosmetics and pharmaceuticals with similar efficacy within 3 months before starting the study. ?Those who have undergone any dermatologic procedures within 6 months. ?Those who are participating in the same clinical study/studies conducted by Ellead or other clinical institution on the same body site/sites. ?Those who have been judged by the research director to be unsuitable for enrollment in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of itch(VAS method), stratum corneum water content, TEWL, redness(dermatological assessment) before the application of the test material and immediately after application of the test product - after 4 weeks of continuous use. | — |
Countries
Asia(except Japan)
Contacts
LION CORPORATION Global Development Center